🇺🇸 FDA
Patent

US 8722896

Prokineticin receptor antagonists and uses thereof

granted A61PA61P1/00A61P25/00

Quick answer

US patent 8722896 (Prokineticin receptor antagonists and uses thereof) held by The Regents of the University of California expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P25/00, A61P25/04, A61P25/20